Castle Biosciences (CSTL)'s 30-day implied volatility (IV30) was 53.8% at the close on October 16, 2026, up from 41.6% the day before, against a 52-week range of 26.7% to 79.7%. Its 20-day historical volatility was 50.5%.
Data as of October 16, 2026.